Bio tech company updates — 11/18/2026
This health signal was created by a user. It may contain unverified medical claims. Always consult a qualified healthcare professional before making health decisions.
Lotte Biologics has completed its first plant at the Songdo Bio Campus, marking a new step in its push into contract development and manufacturing. The facility is reported to have 120,000 liters of capacity, with commercial production targeted for 2027; the company has also set a 1 trillion won sales target for 2030.
Key Findings
- Lotte Biologics completed its first Songdo Bio Campus plant, with commercial production targeted for 2027.
- The plant is reported to have 120,000 liters of capacity, while Lotte Biologics is targeting 1 trillion won in sales by 2030.
Details
Lotte Biologics held a completion ceremony for Plant 1 at its Songdo Bio Campus on November 18, according to a press release.

The plant’s reported capacity is 120,000 liters, and commercial production is targeted for 2027. Lotte Biologics has also set a 2030 sales target of 1 trillion won.

Sources
Lotte Biologics Opens Songdo Plant, Targets 1 Trillion Won in 2030 Sales - Seoul Economic Daily
Korean Biotechs Head to BIO-Europe to Pitch Obesity, Cancer Drugs - Seoul Economic Daily
Korea
prnewswire.com
en.sedaily.com
en.sedaily.com
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.